One-Dose Rabies Vaccine
One-dose recombinant RABV-G vaccine candidate for single-contact immunization of free-roaming dogs and wildlife—enabling regional rabies elimination.
→Research Pipeline
Lead programs include a one-dose rabies vaccine candidate and a bio-targeted neural interface for motor rehabilitation, alongside dermatology, regenerative medicine, and metabolic disease programs.
Bio-Targeted Neural Interface
Peripheral motor-intention readout for neural rehabilitation, prosthetic control, and closed-loop assistive systems.
→Recombinant Human Type III Collagen
Mammalian cell–expressed recombinant human collagen with triple-helical structure and post-translational modifications.
→SSD624
Candidate biologic for seborrheic dermatitis and related inflammatory skin conditions.
→Long-acting Urate Oxidase
Engineered urate oxidase candidate designed for extended half-life in hyperuricemia and gout-related metabolic disease.
→Hair Follicle Regeneration
Autologous follicle-derived cell expansion and translational regenerative medicine for hair biology.
→